000			01536 a2200433 4500
005			20250517035748.0
264		0	_c20160315
008			201603s 0 0 eng d
022			_a1548-5609
024	7		_a10.1053/j.ackd.2015.03.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aMacLachlan, Lara S
245	0	0	_aNew treatments for incontinence. _h[electronic resource]
260			_bAdvances in chronic kidney disease _cJul 2015
300			_a279-88 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdrenergic beta-3 Receptor Agonists _xtherapeutic use
650	0	4	_aBotulinum Toxins, Type A _xtherapeutic use
650	0	4	_aElectric Stimulation
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIntermittent Urethral Catheterization
650	0	4	_aLumbosacral Plexus
650	0	4	_aMale
650	0	4	_aMuscarinic Antagonists _xtherapeutic use
650	0	4	_aNeuromuscular Agents _xtherapeutic use
650	0	4	_aPhysical Therapy Modalities
650	0	4	_aSuburethral Slings
650	0	4	_aTibial Nerve
650	0	4	_aTissue Engineering
650	0	4	_aUrinary Catheterization
650	0	4	_aUrinary Diversion
650	0	4	_aUrinary Incontinence _xtherapy
650	0	4	_aUrinary Incontinence, Stress _xtherapy
650	0	4	_aUrinary Incontinence, Urge _xtherapy
700	1		_aRovner, Eric S
773	0		_tAdvances in chronic kidney disease _gvol. 22 _gno. 4 _gp. 279-88
856	4	0	_uhttps://doi.org/10.1053/j.ackd.2015.03.003 _zAvailable from publisher's website
999			_c24995091 _d24995091